Production of fibronectin binding protein A at the surface of lactococcus lactis increases plasmid transfer In vitro and in vivo by Pontes, Daniela Santos et al.
Production of Fibronectin Binding Protein A at the
Surface of Lactococcus lactis Increases Plasmid Transfer
In Vitro and In Vivo
Daniela Pontes1,2., Silvia Innocentin1,2., Silvina del Carmen3, Juliana Franco Almeida1,2, Jean-
Guy LeBlanc3, Alejandra de Moreno de LeBlanc3, Se´bastien Blugeon1,2, Claire Cherbuy1,2,
Franc¸ois Lefe`vre4, Vasco Azevedo5, Anderson Miyoshi5, Philippe Langella1,2, Jean-Marc Chatel1,2*
1 INRA, UMR1319 Micalis, Jouy-en-Josas, France, 2AgroParisTech, UMR Micalis, Jouy-en-Josas, France, 3CERELA-CONICET, San Miguel de Tucuma´n, Argentina, 4 INRA, VIM,
Domaine de Vilvert, Jouy-en-Josas, France, 5 Institute of Biological Sciences, Federal University of Minas Gerais (UFMG-ICB), Belo Horizonte, Minas Gerais, Brazil
Abstract
Lactococci are noninvasive lactic acid bacteria frequently used as protein delivery vectors and, more recently, as DNA
delivery vehicles. We previously showed that Lactococcus lactis (LL) expressing the Fibronectin-Binding Protein A of
Staphylococcus aureus (LL-FnBPA+) showed higher internalization rates in vitro in Caco-2 cells than the native (wt) lactococci
and were able to deliver a eukaryotic Green Fluorescent Protein (GFP) expression plasmid in 1% of human Caco-2 cells. Here,
using the bovine beta-lactoglobulin (BLG), one of the major cow’s milk allergen, and GFP we characterized the potential of
LL-FnBPA+ as an in vivo DNA vaccine delivery vehicle. We first showed that the invasive strain LL-FnBPA+ carrying the
plasmid pValac:BLG (LL-FnBPA+ BLG) was more invasive than LL-BLG and showed the same invasivity as LL-FnBPA+. Then
we demonstrated that the Caco-2 cells, co-incubated with LL-FnBPA+ BLG produced up to 30 times more BLG than the
Caco-2 cells co-incubated with the non invasive LL-BLG. Using two different gene reporters, BLG and GFP, and two different
methods of detection, EIA and fluorescence microscopy, we showed in vivo that: i) in order to be effective, LL-FnBPA+
required a pre-coating with Fetal Calf Serum before oral administration; ii) plasmid transfer occurred in enterocytes without
regard to the strains used (invasive or not); iii) the use of LL-FnBPA+ increased the number of mice producing BLG, but not
the level of BLG produced. We thus confirmed the good potential of invasive recombinant lactic acid bacteria as DNA
delivery vector in vivo.
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Introduction
Attenuated pathogens that have the ability to invade eukaryotic
cells, such as Listeria, Salmonella or Shigella, have been used to deliver
DNA constructs into mammalian cells since many years [1]. Lactic
acid bacteria (LAB), such as Lactococcus lactis, a non-colonizing,
transiting LAB are used intensively to deliver proteins at the
mucosal level [2]. We have recently showed that L. lactis, was able
to transfer a fully functional plasmid in vitro [3] and in vivo [4] to
eukaryotic cells. Previously, we had demonstrated that lactococci
expressing Internalin A (InlA) from Listeria monocytogenes, the
protein responsible for the invasivity of L. monocytogenes, were able
to deliver a plasmid in vitro and to invade epithelial membrane in
vivo [5]. However, since InlA did not bind to its murine receptor,
E-cadherin, we developed a new recombinant invasive L. lactis
strain by expressing at its surface the Fibronectin Binding Protein
A (FnBPA) from Staphylococcus aureus hereafter called LL-FnBPA+
[6]. FnBPA was previously produced successfully in lactococci to
study its role in the invasivity of S. aureus [7]. We showed that LL-
InLA+ and LL-FnBPA+ had comparable invasiveness rates that
were 100 to 1000 fold higher than the invasiveness rate of the
native (wt) L. lactis strain. Moreover, they were able to deliver
a fully functional plasmid in vitro [6].
Here, we studied in vitro and in vivo the ability of LL-FnBPA+ to
deliver the plasmid pValac [8] containing either the cDNA of
bovine beta-lactoglobulin (BLG), one of the major cow’s milk
allergen and our model antigen, or the cDNA of Green
Fluorescent Protein (GFP) under the control of a eukaryotic
promoter. Co-incubation of LL-FnBPA+ BLG and Caco-2 cells
led to 30-fold more BLG produced compared to the non-invasive
LL-BLG strain. After oral administration with LL-FnBPA+ BLG
or LL- BLG, BLG was detected in isolated enterocytes confirming
our previous hypothesis [4]. We confirmed this result using
fluorescence microscopy after oral administration with LL-
FnBPA+ GFP. Since the number of mice expressing BLG was
increased, but not the expression level using invasive strain, we
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concluded that invasive lactococci increased the plasmid transfer
frequency but not the quantity of the plasmid that was transferred.
Moreover, the differences observed between our in vitro and in vivo
results suggest that the mechanism of plasmid transfer could be
different.
Results
L.lactis strain producing FnBPA and carrying pValacBLG
invades Caco-2 cells in vitro with the same efficiency than
LL-FnBPA+
pValac:BLG was transformed in the recombinant invasive
strain LL-FnBPA+ previously described [6]. We compared the
ability of LL-FnBPA+ strain carrying or not pValacBLG to invade
Caco-2 cells by the gentamicin survival assay. The results showed
us that LL-FnBPA+ BLG is approximately 10 fold more invasive
than LL-wt and LL-BLG. Moreover LL-FnBPA+ BLG strain is
able to invade Caco-2 cells in the same extent than the LL-
FnBPA+ strain (Fig. 1).
LL-FnBPA+ BLG is more efficient DNA delivery vector in
vitro than LL-BLG
Briefly, LL-FnBPA+ BLG and LL- BLG were co-incubated
3 hours with Caco-2 cells. The cellular extracts and media from
72 h gentamicin-treated Caco-2 cells were then analyzed using
a highly specific BLG Enzyme Immunometric Assay (EIA). BLG
production was 30-fold more abundant in Caco-2 cell extracts co-
incubated with the invasive strain LL-FnBPA+ BLG than in the
Caco-2 cells extracts co-incubated with the non invasive strain LL-
BLG (Fig. 2A).
BLG was also detected in supernatant of Caco-2 cells co-
incubated with both invasive and non-invasive strains. BLG
secreted in the medium was 20-fold more abundant for Caco-2
cells co-incubated with invasive strain LL-FnBPA+ BLG than for
Caco-2 cells co-incubated with non invasive strain LL- BLG
(Fig. 2B).
The LL-FnBPA+ BLG invasive strain doesn’t transfer
plasmid in vivo
Invasive and non-invasive strains containing pValac:BLG were
orally administered daily 3 times to mice. 24 hours after the last
gavage, enterocytes of the small intestine were isolated and BLG
was assayed in the protein extracts of the enterocytes. BLG was
detected in isolated enterocytes of mice administered with non
invasive LL-BLG strain but not in mice administered with the LL-
FnBPA+ BLG invasive strain (Fig. 3). As free fibronectin (Fn) is
required for the binding of FnBPA to its receptor, a5b1 integrins,
at the surface of the enterocytes, in further experiments our strains
will be pre-incubated in Fetal Calf Serum (FCS) 10%, which is
known to contain Fn, before in vivo administration.
The LL-FnBPA+ BLG strain is slightly more invasive in vivo
than LL- BLG
LL- BLG and LL-FnBPA+ BLG pre-incubated in FCS 10%
were orally administered to mice. One hour after the gavage mice
were sacrificed. The internalized lactococci were enumerated in
the whole small intestine 60 min after infection (after gentamicin
treatment to kill extracellular bacteria from the intestinal lumen).
The difference between both groups was not statistically significant
due to the heterogeneity of the response in the group of mice
administered with invasive bacteria (Fig. 4). We tested different
Figure 1. Invasiveness assays of bacteria into Caco-2 human
epithelial cells. Caco-2 cells were co-incubated with LL-wt, LL-BLG, LL-
FnBPA+ BLG and LL-FnBPA+ during 1 hour and then treated with
gentamicin for 2 hours. Cells were lysed and the number of CFU
internalized was measured by plating. *, survival rates were significantly
different of LL-wt and LL-BLG (One-way ANOVA, Bonferroni’s multiple
comparison test, p,0.05). The results presented are from one
experiment representative of three performed independently.
doi:10.1371/journal.pone.0044892.g001
Figure 2. BLG production in Caco-2 cells after coincubation
with LL-FnBPA+ BLG or LL-BLG. Caco-2 cells were co-incubated
with LL-BLG and LL-FnBPA+ BLGduring 3 hours. BLG was assayed
72 hours after co-incubation in cellular protein extracts (A) or medium
(B). *, BLG production was significantly different (Student t test,
p,0.05). The results presented are the sum of three independent
experiments.
doi:10.1371/journal.pone.0044892.g002
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time after oral administration from 30 to 90 min, different amount
of bacteria and similar results were observed (data not shown).
However the number of bacteria internalized was slightly higher in
mice administered with invasive strain.
Oral administration of the invasive LL-FnBPA+ BLG pre-
incubated in FCS led to higher number of mice
producing BLG
Invasive and non-invasive strains containing pValac:BLG were
pre-incubated in FCS 10% and then orally administered to mice.
24 hours after the last gavage, enterocytes of the small intestine
were isolated and BLG was assayed after protein extraction.
Similar amounts of BLG were detected in protein extracts of mice
administered with either LL-FnBPA+ BLG or LL-BLG strain
(Fig. 5). In each individual experiment, the number of mice
producing BLG was higher in the group administered with
invasive bacteria than with non invasive bacteria. The proportion
has even reached 100% in one of the experiments.
Oral administration of the invasive LL-FnBPA+ GFP
showed protein expression in small intestinal epithelial
cells
The invasive strain LL-FnBPA+ GFP that was orally admin-
istered to mice demonstrated that the pValac vector is able to
express heterologous proteins in the small intestinal epithelial cells
as shown by the presence of GFP expressing cells (Fig. 6). In each
individual experiment, fluorescent epithelial cells were only
observed in mice that received LL-FnBPA+ GFP whereas no
fluorescent epithelial cells were observed in animals that received
the same strain without the expression vector (strain LL-FnBPA+)
or that did not receive bacterial supplementation.
Discussion
We previously showed that, in vitro, the invasive L. lactis FnBPA+
strain was internalized more efficiently (100-1000-fold more) than
the non invasive strain LL-wt [6]. In this study, we showed in vitro
that the use of LL-FnBPA+ to deliver pValac:BLG enhanced 30
fold the production of BLG compared to the use of LL-wt strain.
Thus by enhancing internalization of our bacteria we were able to
increase plasmid transfer to eukaryotic cells. In this paper the
plasmid transfer is monitored by the detection of our protein
reporter BLG or GFP. Further experiments allowing the
monitoring of plasmid DNA are in progress.
Intriguingly, no production of BLG in enterocytes of mice was
detected after oral administration of the invasive strain. We had
observed by microscopy that the invasive strain are more
susceptible to aggregation than the non-invasive strain (data not
shown). FnBPA is a multifunctional adhesion protein interacting
with its receptor, the a5b1 integrins, via fibronectin (Fn) [9,10]. In
these aggregates, FnBPA could not be accessible thus preventing
any interaction with integrins. This observation was reverted when
the invasive strain was pre-incubated in FCS 10% (data not
shown) and oral administration of LL-FnBPA+ BLG pre-in-
cubated in FCS led to the production of BLG in mice in vivo. FCS
is known to contain Fn which has been described crucial for
FnBPA-mediated bacterial internalization. In order to measure the
importance of the local concentration of Fn in internalization,
Figure 3. BLG production in isolated small intestine enter-
ocytes of mice orally adminstered with LL-FnBPA+ BLG or LL-
BLG. Mice were orally administered 3 days consecutively with LL-wt LL-
BLG or LL-FnBPA+ BLG. Seventy two hours after the last gavage mice
were sacrified and BLG was assayed in protein extracts from isolated
small intestine enterocytes. The results presented are from one
experiment representative of two performed independently.
doi:10.1371/journal.pone.0044892.g003
Figure 4. Invasiveness assay of LL-BLG and LL-FnBPA+ BLG
strains in vivo. Mice were orally administered with LL-BLG and LL-
FnBPA+ BLGpre-incubated in FCS. One hour after the gavage mice were
sacrificed. The internalized lactococci were enumerated in the whole
small intestine 60 min after infection (after gentamicin treatment to kill
extracellular bacteria from the intestinal lumen).
doi:10.1371/journal.pone.0044892.g004
Figure 5. BLG production in isolated small intestine enter-
ocytes of mice orally adminstered with LL-FnBPA+ BLG or LL-
BLG strain pre-incubated with FCS. Mice were orally administered
3 days consecutively with LL-wt LL-BLG or LL-FnBPA+ BLG preincubated
with FCS. Seventy two hours after the last gavage mice were sacrified
and BLG was assayed in protein extracts from isolated small intestine
enterocytes. *, BLG production was significantly different (One-way
ANOVA, Bonferroni’s multiple comparison test, p,0.05). The results
presented are the sum of two independent experiments.
doi:10.1371/journal.pone.0044892.g005
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Dziewanowska et al. [10] used two different cell lines: i) MACT-T
producing constitutively Fn; and ii) HEp-2 lacking of Fn pro-
duction [11]. In initial experiments, they depleted MAC-T cell
cultures of exogenous Fn and then supplemented with known
quantities of Fn. In this latter case case, internalization of S. aureus
was blocked in the presence of very small quantities of exogenous
Fn. A saturation of host cell integrins with bovine Fn produced by
the MAC-T cells was suspected. Supplementing cultures with
additional soluble Fn presumably resulted in its binding to FnBPA,
strongly limiting the interaction with Fn on the MAC-T cell
surface. These authors confirmed this prediction using HEp-2 cells
by showing a clear dose-response effect in which small quantities of
Fn (up to 5 nM) stimulated uptake and higher quantities (above
25 nM) inhibited internalization; demonstrating that local Fn
concentration is crucial for FnBPA’s binding to integrins.
Previously we had investigated the invasivity of L. lactis
expressing InlA from L. monocytogenes (LL-InlA+) in guinea pig in
vivo [5]. The conclusions were that LL-InlA+ are more invasive in
vivo than wt strain and that the difference was higher very early,
30 min, after oral administration. Here no statistically significant
difference was detected between invasive and non invasive strain
even if the number of bacteria surviving the gentamycin assay was
always higher in the group of mice orally administered with
invasive LL-FnBPA+. We tested different time after oral admin-
istration from 30 to 90 min, different amount of bacteria and
similar results were observed (data not shown).
In one of our previous studies [4] we hypothesized that plasmid
transfer could occur in enterocytes. Enterocytes were the most
evident target for plasmid transfer because: i) they were the more
abundant cells from the epithelial membrane; ii) they expressed
the receptor for FnBPA, a5b1 integrins; iii) our previous
experiment showed that BLG was not produced more than 5 days
after the last gavage, a time corresponding to the complete renewal
of enterocytes from epithelial membrane. Here, we were able to
detect BLG production in protein extracts from isolated enter-
ocytes confirming our hypothesis that the plasmid transfer occurs
efficiently in enterocytes. Knowing that the isolated enterocytes
are not 100% pure we wanted confirm this result using another
method. We performed fluorescence microscopy experiment in vivo
after oral administration of previously described strain LL-
FnBPA+ GFP [6]. The histological evaluation clearly showed that
at least some epithelial cells from mice that received LL-FnBPA+
containing pValac-GFP properly expressed GFP. However, we
cannot discard the possibility that other cells (such as dendritic
cells) might also be a target for our delivery system.
We were able to detect BLG in the enterocytes of mice after oral
administration of our invasive strain carrying pValac:BLG.
Interestingly, the number of mice producing BLG was always
higher in the group treated with the invasive strain than in the
group administered with the non-invasive strain but the level of
BLG production was the same in both groups of mice. The use of
the invasive strain did not increase the quantity of plasmid
transferred, but was able to increase the probability that the
plasmid transfer event occurs. This small increase could reflect
that just a small part of our bacteria can reach the enterocytes and
interact with them.
It is possible that the number of plasmids able to survive in
eukaryotic cells is limited and that we have already reached this
limit in our experiments. Zelmer et al. [12] described in details the
various crucial parameters involved in plasmid transfer from
Listeria monocytogenes to mammalian cells. They concluded that low-
rates of bacteria-mediated-transfection is due to plasmid DNA
association with higher proteic macromolecular structures inhibit-
ing nuclear transport and thus transgene production. Their results
were obtained in vitro but we can now hypothesize that the same
mechanisms occurs in vivo. The best way to increase the efficiency
of plasmid transfer would not be to enhance the number of
Figure 6. GFP production in small intestines of mice orally administered with LL-FnBPA+ GFP. Histological slides of small intestines of
animals that received LL-FnBPA+ GFP (LL-FnBPA+ GFP group), LL-FnBPA+ (LL-FnBPA+ group) or that did not receive bacterial supplementation
(Control group) observed at different magnifications (160, 400 or 100X) using a fluorescent microscope. Arrows indicate GFP+ epithelial cells.
doi:10.1371/journal.pone.0044892.g006
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plasmid inside the eukaryotic cells, which would be high enough,
but rather to avoid these protein macromolecular structures.
In this study, we confirmed that our invasive strain L. lactis
FnBPA+ is a promising candidate as plasmid delivery vector in vivo.
Moreover, we showed that BLG expression is located in
enterocytes. Further experiments characterizing the type of
immune response are necessary and currently underway.
Materials and Methods
Bacterial strains, plasmids, media and growth conditions
The strains and plasmids used in this study are listed in Table 1.
pValac:BLG is derived from pValac:GFP [8]. The BLG coding
sequence including its signal peptide was cloned in pValac:GFP by
inserting a HindIII-XbaI fragment from pcDNA3BLG [13] instead
of the GFP coding sequence of pValac:GFP. pcDNA3BLG was
digested by HindIII and XbaI and the resulting fragment was
purified from an agarose gel, then ligated with pValac:GFP
previously digested with HindIII and XbaI and dephosphorylated.
The product of ligation was transformed in Escherichia (E.) coli
Top10. Positive clones were first screened by PCR using BLG
specific primers then by restriction enzyme digestion and
sequencing. After amplification and purification, pValac:BLG
was transformed in L. lactis subsp. cremoris MG1363 as described
previously [14].
L. lactis subsp. cremoris strains were grown in M17 medium
containing 0.5% glucose (GM17) at 30uC. E. coli strains were
grown in Luria–Bertani medium and incubated at 37uC with
vigorous shaking. Antibiotics were added at the indicated
concentrations as necessary: erythromycin, 500 mg/ml for E. coli,
and 5 mg/ml for L. lactis; chloramphenicol, 10 mg/ml for both E.
coli and L. lactis.
Apparatus and reagents
All enzymatic immunoassays were performed in 96-well
microtitre plates (Immunoplate Maxisorb, Nunc, Roskilde, Den-
mark) using specialized Titertek microtitration equipment from
Labsystems (Helsinki, Finland). Unless otherwise stated, all
reagents were of analytical grade from Sigma (St Louis, MO,
USA). BLG was purified from cow’s milk as previously described
[15].
Mice handling
Specific pathogen-free BALB/c mice (females, 6 weeks of age;
Janvier, France) were maintained under normal husbandry
conditions in the animal facilities of the National Institute of
Agricultural Research (UEAR, INRA, Jouy-en-Josas, France). All
animal experiments were started after the animals were allowed
2 weeks of acclimation and were performed according to
European Community rules of animal care and with authorization
78–149 of the French Veterinary Services.
Invasiveness assays of L. lactis strains in Caco-2 human
epithelial cells
The coculture assays were performed with the human colon
carcinoma cell line Caco-2 (ATCC HTB37), as described by
Dramsi et al. [16] and Innocentin et al. [6]. Briefly, these cells
were cultured in RPMI supplemented with 2 mM L-glutamine
(BioWhittaker, Cambrex Bio Science, Verviers, Belgium) and 10%
fetal calf serum (complete RPMI). Under these experimental
conditions, Caco-2 cells from passages 85 to 87 were used and
maintained without antibiotics. The number of cells tested was
46105 per dish. L. lactis strains were grown to an optical density at
600 nm of 0.9 to 1.0, washed, and diluted in 1x Phosphate
Buffered Saline (PBS) so that the multiplicity of infection was
about 103 bacteria per cell, giving about 46108 per dish. Caco-2
epithelial cells were co-incubated with (i) LL-wt, (ii) LL- BLG, (iii)
LL-FnBPA+ BLG and (iv) LL-FnBPA+. After 1 h of coculture, the
cells were washed with complete RPMI without antibiotics and
incubated for 2 h in the same medium with gentamicin (150 mg/
liter) to kill noninternalized lactococci. Cells were washed and
lysed in 0.2% Triton X-100 and serial dilutions of the lysate were
plated for bacterial counting.
Coculture assays of L. lactis strains and Caco-2 human
epithelial cells
The coculture assays were performed as described above. Caco-
2 epithelial cells were cocultivated with (i) LL-wt, (ii) LL- BLG, and
(iii) LL-FnBPA+ BLG. After 3 h of coculture, the cells were
incubated for 2 h in complete RPMI medium with gentamicin
(20 mg/liter) to kill noninternalized lactococci (12). Cells were
collected 72 h after gentamicin treatment; rinsed with PBS; and
proteins were extracted as described above.
BLG extraction and detection in Caco-2 cells
At 72 h after gentamicin treatment, the medium (M) was
collected and Caco-2 cells were harvested, centrifuged in
phosphate-buffered saline (PBS), counted, and sonicated. The
cellular extract was centrifuged for 15 min at 10,000 g at 4uC.
The supernatant (S), containing the soluble proteins, was collected.
Native BLG (nBLG) was assayed in M and S extracts by a specific
two-site enzyme immunometric assay (EIA) described below.
Table 1. Strains and plasmids used in the study.
Strains or Plasmids Properties Reference
LL-FnBPA+ L. lactis strain expressing the FnBPA cDNA Que et al., 2001
LL-wt L. lactis strain carrying pIL253 plasmid Simon & Chopin, 1988
LL- BLG L. lactis strain carrying pIL253 and pValac:BLG plasmid This study
LL-FnBPA+ BLG L. lactis strain expressing FnBPA and carrying pValac:BLG This study
pOri23-FnBPA L. lactis-E. coli shuttle vector carrying FnBPA gene from S. aureus, Eryr Que et al., 2001
LL-FnBPA+ GFP L. lactis strain expressing FnBPA and carrying pValac:GFP Innocentin et al., 2009
pValac:BLG L. lactis-E. coli shuttle vector carrying the blg cDNA under the control
of the eukaryotic promoter CMV, Cmr
This study
Eryr, Erythromycin; Cmr, Chloramphenicol.
doi:10.1371/journal.pone.0044892.t001
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Oral administration, enterocytes isolation from the small
intestine and protein extraction from enterocytes
Strains were grown to saturation (overnight (ON) cultures).
Before oral administration strains were centrifuged 10 min,
5,000 g at 4uC, and then resuspended in PBS to wash the
bacteria. In the experiment described in Fig. 4 washed bacteria
were centrifuged again and the pellet was resuspended in PBS
containing Fetal Calf Serum 10% to provide fibronectin during
2 hours at 4uC. Then the strains were pelleted and resuspended in
PBS. Group of mice (n = 8) were fed orally with 1010 CFU/mouse
during 3 days. Three days after the last gavage, mice were killed
and the small intestine was withdrawn. Gut contents were
removed by washing with 15 ml of PBS. Enterocytes were isolated
as described previously [17]. Briefly small intestine was cut
longitudinally and then infused for 20 minutes at 37uC with a Ca2+
and Mg2+ free Krebs–Henseleit bicarbonate buffer (ph 7.4),
containing 10 mmol/L HEPES, 1 mmol/L EDTA, 1 mmol/L
dithiothreitol, and 0.25% BSA. Isolated cells were resuspended in
PBS containing Triton X100 0.2% for 10 min at 4uC. After
homogenization by pipetting, lysed cells were centrifuged 10 min,
10,000 g at 4uC and the supernatant was discarded. BLG was
assayed on supernatant as described below.
BLG enzyme immunometric assay
Two-site enzyme immunometric assays (EIA) for native BLG
(BLGn) were performed as previously described (8). Briefly, assays
were performed in 96-well microtitre plates coated with a mono-
clonal antibody (mAb) specific for BLGn. Fifty ml of standard or of
the samples was added; then 50 ml of tracer was added, consisting
of a second mAb labelled with AChE. After 18-h reaction at 4uC,
the plates were washed and solid–phase-bound AChE activity was
measured using Ellman’s method (3). A detection limit of 30 pg/
ml was obtained.
GFP detection in enterocytes from the small intestine
Strain LL-FnBPA+ containing pValacGFP or LL-FnBPA+
without the expression vector were grown and prepared as
described above. Mice were fed by gavage with 108 UFC/mouse
orally. After 24 h of post-administration, mice were sacrificed and
small intestine were removed, washed with PBS and prepared for
histological evaluation using standard techniques. Serial paraffin
sections (4 mm) were made and prepared for direct observation at
160, 400 and 1000X using a fluorescence light microscope.
Invasiveness assay in mice
Oral administration of lactococci was performed as described
above. Group of mice (n = 3) were fed orally with 1010 CFU/
mouse. At 60 min after inoculation, the whole small intestine was
sterilely dissected, rinsed in Dulbecco’s modified Eagle’s medium
(DMEM, Gibco) to remove the intestinal content, incubated at
20uC for 2 h in DMEM containing 150 mg/L gentamicin (Gibco)
to kill extracellular bacteria from the intestinal lumen, and rinsed
three times in DMEM. The number of bacterial colony forming
units (cfu) was determined by plating serial dilutions of intestine
homogenates on solid GM17.
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